Oppenheimer maintains Ridgepost Capital at Outperform, lowers price target to $14 from $15
Oppenheimer kept its Outperform rating on Ridgepost Capital but reduced its price target to $14 from $15, a 6.7% decrease. The new target suggests a 44.6% upside from the Nov 4 close of $9.68, according to the firm.
How this was made

The 30-second read
Why it matters
The downgrade suggests modest downside pressure but limited market impact due to low float.
Market read
Minor analyst rating change with limited trading relevance.
What to watch
Liquidity constraints and limited analyst coverage could amplify price moves.
Background
Oppenheimer lowered its price target for Ridgepost Capital, a micro‑cap, from $15 to $14.
Market effects
none
none
none
Counterpoint
The price target cut may be overly cautious for a thinly traded microcap.
Key entities
- companyRidgepost Capital
Micro‑cap company covered by Oppenheimer

